How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

New method to tune LLMs is RLMF, reinforcement learning with metacognitive feedback. It is akin to RLAIF and somewhat like ...

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted ...

The new "Claude Science" from Anthropic uses artificial intelligence to tackle rare genetic disorders and tropical maladies, ...

I know I’m old because I remember when a B+ was a respectable grade. Now it’s more like an indictment. I’m a masochist if I ...

Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. https://doi.org/10.2307/j.ctvjnrt76.5 https ...

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

The loop takes agentic AI a step further, by authorizing a swarm of agents to work continuously in the background, endlessly.

Architecture delivery. The stories were vehicles; the real payload was a way of organizing experience into causal, moral, and ...

What explains the increasingly volatile mood swings of America’s most important industry?

Cursor IDE zero-day vulnerability: AI security firm Mindgard spent seven months trying to report a Windows code-execution ...

MetLife's CMO, Michael Roberts, is leveraging the World Cup not for mere branding, but to solidify the company's core purpose: building a more confident future.